COMMUNIQUÉS West-GlobeNewswire

SafeSpace Global Corp. (OTCID: SSGC) to Present at the Sidoti Micro-Cap Virtual Conference on May 21st
19/05/2026
Knoxville, TN., May 19, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation ("SafeSpace" or the "Company") (OTCID: SSGC), a provider of multimodal AI-powered physical safety and security technologies designed to [...]
BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution)
19/05/2026
MISSISSAUGA, Ontario, May 19, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that Health Canada has approved Thyconvi™ (levothyroxine sodium), the first and only [...]
ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026
19/05/2026
Company continues expanding commercial presence across critical care markets TYLER, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a commercial-stage [...]
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
19/05/2026
Oral presentation at ERA Congress, the flagship European nephrology meeting Company expects to present additional data TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage [...]
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones
19/05/2026
Alliance Global Partners and Maxim Group Initiate Separate NeOnc Technologies Coverage with Favorable Ratings DENVER, May 19, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com ) – NeOnc Technologies (NASDAQ: NTHI ), a [...]
Joshua Fritzler Named President of Olympia and Wesley Pharmaceuticals
19/05/2026
Executive promotion signals strategic growth and continued expansion of state-of-the-art 503A and 503B compounding operations ORLANDO, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of [...]
Commure Raises $70M at $7B Valuation to Transform Healthcare Operations Using AI
19/05/2026
MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Commure , the AI platform for healthcare, today announced $70 million in financing at a $7 billion post-money valuation. The round was led by General Catalyst, [...]
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
19/05/2026
SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that shareholders elected Scott R. [...]
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
19/05/2026
JUPITER, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic,” “we,” “us,” “our,” or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing [...]
Nord Pilates Surpasses 1,300 Customer Reviews as Women Praise Personalized Pilates Plans and Low-Impact Home Workouts
19/05/2026
Real users report visible results and improved consistency with Nord Pilates's personalized workout plans and daily habit tracking tools NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Nord Pilates has launched a [...]
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
19/05/2026
ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two aseptic suites [...]
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
19/05/2026
Potential best-in-class therapeutic delivered subcutaneously (GalNAc-conjugated oligonucleotide) for a debilitating genetic condition impacting both the liver and lungs Demonstrated >90% editing of SERPINA1 [...]
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
19/05/2026
Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture and virtual-care infrastructure already deployed at UCSD HOUSTON, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Nexalin [...]
Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
19/05/2026
Base shelf prospectus is accessible, and prospectus supplement will be accessible within two business days on SEDAR+ 1 TORONTO and HOUSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or [...]
Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21
19/05/2026
Sarasota, FL, May 19, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company"), a clinical-stage biopharmaceutical company pioneering neurological therapeutics, will present and host [...]
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
19/05/2026
Provides End-To-End Services for Preclinical & Clinical Projects with Extensive Experience in Decoding Biologics Production MELBOURNE, Australia, May 19, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: [...]
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
19/05/2026
Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wall Patent strengthens intellectual property foundation for next-generation neuromodulation [...]
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
19/05/2026
NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk- [...]
Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib
19/05/2026
HIGHLIGHTS New Phase 2b study builds on compelling Phase 1b/2a ACCENT study data to lay foundation for Phase 3 registrational study Focus on investigating new, daily dosing of narmafotinib in combination with standard [...]

Pages